1973
DOI: 10.1159/000467975
|View full text |Cite
|
Sign up to set email alerts
|

A Controlled Evaluation of Pyrovalerone in Chronically Fatigued Volunteers

Abstract: Ten menopausal chronically fatigued volunteers received 2 doses of pyrovalerone and a placebo in a double-blind, multiple crossover design. No significant drug-placebo differences were obtained, but the second administration of the drug at 20 mg TID was the most effective drug condition, producing significant improvement on the POMS factors of Fatigue, Confusion, and Tension-Anxiety, and significant weight reduction. The higher dose (40 mg TID) also reduced weight and Confusion, but produced many side effects.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(26 citation statements)
references
References 9 publications
0
25
0
1
Order By: Relevance
“…Despite the widespread use of MDPV, no information is available regarding its molecular mechanism of action. Older literature demonstrates that pyrovalerone, a compound with structural similarity to MDPV, displays amphetamine-like stimulant properties in rodents (Fauquet et al, 1976;Vaugeois et al, 1993) and humans (Goldberg et al, 1973;Holliday et al, 1964). Bonnet and colleagues (Heron et al, 1994;Tidjane Corera et al, 2001) showed that pyrovalerone is a dopamine uptake blocker that interacts with transporter proteins in a manner similar to cocaine.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the widespread use of MDPV, no information is available regarding its molecular mechanism of action. Older literature demonstrates that pyrovalerone, a compound with structural similarity to MDPV, displays amphetamine-like stimulant properties in rodents (Fauquet et al, 1976;Vaugeois et al, 1993) and humans (Goldberg et al, 1973;Holliday et al, 1964). Bonnet and colleagues (Heron et al, 1994;Tidjane Corera et al, 2001) showed that pyrovalerone is a dopamine uptake blocker that interacts with transporter proteins in a manner similar to cocaine.…”
Section: Introductionmentioning
confidence: 99%
“…Also known as "Cat" and "Jeff," it has been used recreationally most often in countries formerly part of the Soviet Union, but also gained popularity in the United States, particularly in Michigan, in the 1990s [7]. Another derivative, pyrovalerone was investigated for use as a prescription drug to treat chronic fatigue, lethargy, and obesity but was withdrawn due to abuse and dependency in users [8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…Despite these indications that MDPV may be a growing public health concern, it remains the case that scant information is available regarding its mechanism of action or in vivo effects. In this regard, the structurally similar pyrovalerone has been shown to stimulate spontaneous locomotor activity in rodents (Fauquet et al, 1976;Vaugeois et al, 1993) and to induce stimulant-like actions in humans (Holliday et al, 1964;Goldberg et al, 1973). More recently, it was demonstrated that pyrovalerone has cocaine-like effects at dopamine reuptake transporters (Heron et al, 1994;Tidjane Corera et al, 2001;Meltzer et al, 2006) and that these effects are also apparent in MDPV itself (Baumann et al, 2012b;Simmler et al, 2012).…”
Section: Introductionmentioning
confidence: 99%